Webinar | How Will Microbiome Reshape Anti-Aging Skin Care in 2026 Register Here

company svgrepo com

Synaura

Synaura manufactures, provides, and develops human milk oligosaccharides (HMO) for breastfed babies.
2022
10001+
Shanghai, Shanghai, China

Investment Funding

Last Funding Stage

Series A

Total Funding Amount

13.85M

Last Funding Date

22-10-2024

Startup Stage

Early Stage

Lead Investors

China Mengniu Dairy, Kweichow Moutai, CICC Qide, Zhongjin Qide

Something missing or incorrect on this page? Help us enrich this information